학술논문

Short-cycle therapy (5 days on/2 days off) with a lamivudine + dolutegravir regimen in a cohort of virologically suppressed patients with HIV infection.
Document Type
Article
Source
International Journal of Antimicrobial Agents. Mar2021, Vol. 57 Issue 3, pN.PAG-N.PAG. 1p.
Subject
*HIV-positive persons
*LAMIVUDINE
Language
ISSN
0924-8579
Abstract
Short-cycle therapy (5 days on/2 days off) with a lamivudine + dolutegravir regimen in a cohort of virologically suppressed patients with HIV infection. [Extracted from the article]